학술논문
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment
Document Type
Article
Author
Source
In: Gynecologic Oncology . (Gynecologic Oncology, October 2023, 177:60-71)
Subject
Language
English
ISSN
10956859
00908258
00908258